drugset

drugset / Trial / NCT00402389

Use of Omega-3 Fatty Acids for Perinatal Depression

NCT00402389 ↗

Phase 2 Completed 50 enrolled University of Arizona National Institute of Mental Health (NIMH) · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.

Timeline

Start: 2004-06
Primary completion: 2006-01
Completion: 2006-01

Publications

Results Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand. 2006 Jan;113(1):31-5. doi: 10.1111/j.1600-0447.2005.00660.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Omega-3 fatty acids	Unknown	0.5 g	Oral
Subject	Omega-3 fatty acids	Unknown	1.4 g	Oral
Subject	Omega-3 fatty acids	Unknown	2.8 g	Oral

Indications